Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

John G. F. Cleland, MD

Articles by John G. F. Cleland, MD

High-Versus Low-dose Angiotensin Converting Enzyme Inhibitor Therapy in the Treatment of Heart Failure: An Economic Analysis of the Assessment of Treatment with Lisinopril and Survival (ATLAS) Trial

ByJ. Sanford Schwartz, MD,Y. Richard Wang, MD, PhD,John G. F. Cleland, MD,Longlong Gao, MS,Mark Weiner, MD,Philip A. Poole-Wilson, MD,fo

June 1st 2003

Latest Updated Articles

High-Versus Low-dose Angiotensin Converting Enzyme Inhibitor Therapy in the Treatment of Heart Failure: An Economic Analysis of the Assessment of Treatment with Lisinopril and Survival (ATLAS) Trial
Published: June 1st 2003 | Updated:

Trending on AJMC

Major Bleeding Prevention, Treatment Requires Vigilance in Patients With ET

Medicare Insulin Savings Model Cuts Costs, Boosts Access, Report Finds

Trust and Transparency Key for Leveraging AI to Expand Access to Precision Oncology

Executive Order on Homelessness Includes Several Policy Shifts: Katherine Koh, MD, MSc

Effective Collaboration Between PCPs, Oncologists Enhances Patient Care: Mark Fendrick, MD

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

© 2025 MJH Life Sciences^®

All rights reserved.